Skip to main content

Elite Pharmaceuticals, Inc. (ELTP)

OTCMKTS: ELTP · IEX Real-Time Price · USD
0.0430 0.0030 (7.50%)
Oct 13, 2021 3:58 PM EDT - Market closed
Market Cap41.87M
Revenue (ttm)24.90M
Net Income (ttm)6.40M
Shares Out1.01B
EPS (ttm)0.01
PE Ratio7.17
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume427,578
Open0.0403
Previous Close0.0400
Day's Range0.0361 - 0.0430
52-Week Range0.0400 - 0.0900
Beta0.77
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 15, 2021

About ELTP

Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets fo...

IndustryPharmaceuticals
IPO DateJul 23, 1998
Employees43
Stock ExchangeOTCMKTS
Ticker SymbolELTP
Full Company Profile

Financial Performance

Financial Statements

News

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 a...

Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty pharmaceu...

1 month ago - Accesswire

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financ...

Financials for First Quarter Fiscal Year 2022 Ended June 30, 2021 will be released August 16, 2021 NORTHVALE, NJ / ACCESSWIRE / August 10, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (...

2 months ago - Accesswire

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conferenc...

Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical...

4 months ago - Accesswire

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Result...

Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialt...

4 months ago - Accesswire

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launc...

NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has lau...

5 months ago - Accesswire

Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,...

5 months ago - Accesswire

Elite Pharmaceuticals, Inc. Appoints Dr. Jason M. LePree as Vice President of Scientific Affairs

NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products...

9 months ago - Accesswire